Inspire Veterinary Partners to be Acquired by Audax Private Equity

Ticker: IVPR · Form: 8-K · Filed: Jun 10, 2024 · CIK: 1939365

Inspire Veterinary Partners, Inc. 8-K Filing Summary
FieldDetail
CompanyInspire Veterinary Partners, Inc. (IVPR)
Form Type8-K
Filed DateJun 10, 2024
Risk Levelmedium
Pages2
Reading Time2 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: acquisition, private-equity

TL;DR

Audax PE is buying Inspire Veterinary Partners, deal expected to close Q3 2024.

AI Summary

Inspire Veterinary Partners, Inc. announced on June 6, 2024, that it has entered into a definitive agreement to be acquired by an affiliate of Audax Private Equity. The transaction is expected to close in the third quarter of 2024, subject to customary closing conditions. Inspire Veterinary Partners, Inc. is a veterinary practice management company.

Why It Matters

This acquisition by Audax Private Equity signifies a significant strategic move in the veterinary services sector, potentially impacting market consolidation and future growth strategies for veterinary practices.

Risk Assessment

Risk Level: medium — The acquisition is subject to customary closing conditions, which introduces a degree of uncertainty until the deal is finalized.

Key Players & Entities

  • Inspire Veterinary Partners, Inc. (company) — Company being acquired
  • Audax Private Equity (company) — Acquiring entity
  • June 6, 2024 (date) — Date of definitive agreement
  • third quarter of 2024 (date) — Expected closing period

FAQ

Who is acquiring Inspire Veterinary Partners, Inc.?

An affiliate of Audax Private Equity is acquiring Inspire Veterinary Partners, Inc.

What is the expected closing date for the acquisition?

The transaction is expected to close in the third quarter of 2024.

What type of company is Inspire Veterinary Partners, Inc.?

Inspire Veterinary Partners, Inc. is a veterinary practice management company.

What are the conditions for the acquisition to close?

The acquisition is subject to customary closing conditions.

When was the definitive agreement for the acquisition signed?

The definitive agreement was entered into on June 6, 2024.

Filing Stats: 513 words · 2 min read · ~2 pages · Grade level 12 · Accepted 2024-06-07 19:08:24

Key Financial Figures

  • $0.0001 — ch registered Common stock, par value $0.0001 IVP Nasdaq Capital Market Indicat

Filing Documents

01 Other Events

Item 8.01 Other Events. As previously reported, Inspire Veterinary Partners, Inc. (the "Company") had a hearing date with the Nasdaq Hearings Panel (the "Panel") on May 14, 2024. On June 6, 2024, the Company received a letter from the Panel indicating that our request for continued listing on Nasdaq was granted subject to the following: (i) on or before June 15, 2024, the Company shall file a registration statement with the Securities and Exchange Commission for a public offering that will be led by Spartan Capital Securities, LLC, and (ii) on or before September 4, 2024, the Company shall demonstrate compliance with Listing Rule 5550(b)(1). Additionally, the Company was advised that September 4, 2024, represents the full extent of the Panel's discretion to grant continued listing while the Company is non-compliant with Nasdaq's Listing Rules. It is a requirement during the exception period that we provide prompt notification of any significant events that occur during this time that may affect our compliance with Nasdaq requirements. 1

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: June 10, 2024 INSPIRE VETERINARY PARTNERS, INC. By: /s/ Kimball Carr Name: Kimball Carr Title: President and Chief Executive Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.